Diagnostic Imaging
Nuclear medicine imaging uses radioactive tracers to visualize physiological processes in the body. The key modalities are:
Positron Emission Tomography (PET)
PET exploits $\beta^+$ decay, where the emitted positron annihilates with an electron, producing two back-to-back 511 keV gamma rays:
Coincidence detection of these two photons defines a line of response (LOR), enabling 3D image reconstruction. The most common PET tracer is $^{18}$F-FDG (fluorodeoxyglucose), which accumulates in metabolically active tissues such as tumors.
SPECT (Single Photon Emission CT)
SPECT uses gamma-emitting isotopes (primarily $^{99m}$Tc) with a rotating gamma camera and collimator. The 140.5 keV gamma ray from $^{99m}$Tc is ideal for imaging: high enough to penetrate tissue, low enough for efficient detection.
Gamma Cameras
A gamma camera (Anger camera) consists of a collimator, a large NaI(Tl) scintillation crystal, an array of photomultiplier tubes (PMTs), and position-computing electronics. The intrinsic spatial resolution is typically 3-4 mm, limited by the collimator geometry. The detection efficiency depends on the collimator type and the gamma-ray energy.
Therapeutic Applications
Brachytherapy
Sealed radioactive sources ($^{192}$Ir, $^{137}$Cs, $^{125}$I) are placed directly within or adjacent to the tumor. The dose rate at distance r from a point source follows the inverse-square law with attenuation:
where $S_K$ is the air-kerma strength, $\Lambda$ is the dose-rate constant,$g(r)$ is the radial dose function, and $\phi_{\text{an}}$ is the anisotropy function.
Targeted Alpha Therapy (TAT)
Alpha-emitting radioisotopes ($^{223}$Ra, $^{225}$Ac, $^{211}$At) deliver high-LET radiation with a range of only 50-100 $\mu$m in tissue (a few cell diameters). The energy deposited per alpha particle is $\sim$5-8 MeV, causing dense ionization and irreparable DNA double-strand breaks. The advantage is high tumor-cell killing efficiency with minimal damage to surrounding tissue.
Proton Therapy
Proton beams deposit most of their energy at the Bragg peak, whose depth depends on the beam energy. The energy loss is described by the Bethe-Bloch formula:
Key Radiopharmaceuticals
| Isotope | $T_{1/2}$ | Decay Mode | Application |
|---|---|---|---|
| $^{99m}$Tc | 6.01 h | IT (140 keV $\gamma$) | SPECT (bone, cardiac, renal) |
| $^{18}$F (FDG) | 109.8 min | $\beta^+$ (97%) | PET (oncology, neurology) |
| $^{131}$I | 8.02 d | $\beta^-$ (606 keV) | Thyroid cancer therapy |
| $^{177}$Lu | 6.65 d | $\beta^-$ (497 keV) | PRRT, PSMA therapy |
| $^{223}$Ra | 11.4 d | $\alpha$ (5.98 MeV) | Bone metastases therapy |
$^{99m}$Tc is the workhorse of nuclear medicine, used in ~80% of all diagnostic procedures. It is obtained from a $^{99}$Mo/$^{99m}$Tc generator (the "moly cow"), where $^{99}$Mo ($T_{1/2} = 66$ h) decays to $^{99m}$Tc, which is eluted with saline solution.
Dose Calculations
The absorbed dose to a target organ from a source organ is calculated using the MIRD (Medical Internal Radiation Dose) formalism:
where $\tilde{A}(r_S)$ is the cumulated (time-integrated) activity in the source organ and $S(r_T \leftarrow r_S)$ is the dose factor (mean absorbed dose per unit cumulated activity). The cumulated activity is:
The S-factor encapsulates the radiation physics: particle energies, emission probabilities, and the geometry of energy deposition from source to target.
Biological and Effective Half-Life
A radiopharmaceutical is eliminated from the body by two independent processes: physical decay and biological clearance. The total elimination rate is the sum:
The effective half-life is therefore:
The effective half-life is always shorter than both the physical and biological half-lives. For diagnostic imaging, short effective half-lives are desirable to minimize patient dose. For therapy, longer effective half-lives allow sustained dose delivery to the tumor.
LET and RBE
The Linear Energy Transfer (LET) describes the energy deposited per unit path length by ionizing radiation:
The Relative Biological Effectiveness (RBE) compares the biological effect of a given radiation type to a reference radiation (usually $^{60}$Co gamma rays):
High-LET radiation (alpha particles, heavy ions) produces dense ionization tracks, causing clustered DNA damage that is more difficult to repair. The RBE increases with LET up to about 100 keV/$\mu$m (optimal LET), then decreases due to "overkill" (wasted dose beyond that needed to kill a cell). The equivalent dose is:
where $w_R$ is the radiation weighting factor ($w_R = 1$ for photons/electrons,$w_R = 2$ for protons, $w_R = 20$ for alpha particles and heavy ions).
Python Simulation: Nuclear Medicine Physics
Radioactive decay of common radiopharmaceuticals, effective half-life calculations, Bragg peak comparison for proton therapy, and LET-RBE relationship.
Nuclear Medicine Calculations
PythonDecay curves, effective half-life, Bragg peak, and LET-RBE plots
Click Run to execute the Python code
Code will be executed with Python 3 on the server
Fortran Implementation: Dose Calculator
MIRD-based dose calculations for radiopharmaceutical therapy, including effective half-life computation, absorbed dose estimates, and LET/RBE data tables.
Nuclear Medicine Dose Calculator
FortranRadiopharmaceutical properties, dose calculation, and radiation quality factors
Click Run to execute the Fortran code
Code will be compiled with gfortran and executed on the server